about
Focus on adoptive T cell transfer trials in melanomaAdoptive cell transfer: a clinical path to effective cancer immunotherapyOptimal management of metastatic melanoma: current strategies and future directionsCase report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2Emerging drugs for chronic lymphocytic leukaemia.Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media.Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010Targeted immunotherapy of cancer with CAR T cells: achievements and challenges.Engineering T cells for cancer therapy.Designer blood: creating hematopoietic lineages from embryonic stem cells.Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma.A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF.Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.Chemokine-chemokine receptors in cancer immunotherapy.Adoptive T-cell transfer in melanoma.Adoptive cell transfer in autoimmune hepatitis.T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice.Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice.Characteristics of new monomolecular chimeric T-cell receptors to carcinoembryonic antigen.
P2860
Q21328679-C1A511B0-6E78-4F89-B711-6B42ECC80073Q24644774-E22F2774-1B79-4ED0-9CBC-E8F944589F06Q26997338-4B840E41-4E2E-40D5-83E5-5BDAAE7D3321Q29620608-4FE34796-87B5-4C50-AF00-0659AFFB1B81Q30353154-1CD1B954-5A3F-4201-8F23-1DEADE29B20DQ30479723-B0E60994-A32A-4A72-967E-C78E42F1B3ECQ33262643-0A30168F-06D5-43E7-93AE-48F6C39D71C0Q34025234-FF26611D-B326-4457-A014-C574618C25F9Q34270375-7A8B01D6-30A6-44E8-A4D3-912D1EC5BBB6Q36298319-04A156B0-3C9A-4828-9CFD-D46A59C06B5EQ36299248-D04AF1C0-3352-4695-9586-8F845810A6A9Q36496709-9DED5711-882D-43A1-88DB-C84C1174A1F4Q37311057-96FABB02-CB1F-46BD-88CB-F8D2385A61F1Q37708023-B76011B0-E014-44B3-A004-4CF77929ED45Q37773282-6F78FA37-A793-475A-BDE3-32609D63C567Q38068968-13CBFA6E-8862-4BAD-AE78-52F0583EF462Q39035161-6974F489-AB01-4C0F-965F-9D8BB28AB97BQ45873576-AEAA3456-EEF7-428C-BCBC-23CDAA404017Q45876227-EC75CF96-5172-420F-AB65-DD5144CF8A7EQ54471045-17BDDA5F-97CD-46C1-AA4F-E645A989D7DD
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Gene modification strategies to induce tumor immunity.
@ast
Gene modification strategies to induce tumor immunity.
@en
type
label
Gene modification strategies to induce tumor immunity.
@ast
Gene modification strategies to induce tumor immunity.
@en
prefLabel
Gene modification strategies to induce tumor immunity.
@ast
Gene modification strategies to induce tumor immunity.
@en
P2093
P1433
P1476
Gene modification strategies to induce tumor immunity
@en
P2093
Amanda Murphy
Jennifer A Westwood
Maria Moeller
Michele W L Teng
P304
P356
10.1016/J.IMMUNI.2005.03.007
P407
P577
2005-04-01T00:00:00Z